Proliferative Diabetic Retinopathy: Principles and Techniques of Surgical Treatment

Retina: Fourth Edition

Volumn 3-3, Issue , 2005, Pages 2413-2449

  Eliott, Dean ^a   Lee, Michael S ^b   Abrams, Gary W ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84917195016     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-02598-0.50148-8     Document Type: Chapter

References (369)

1. Machemer R, Buettner H, Norton EWD, et al. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol 1971, 75:813.
2. Aaberg TM Vitrectomy for diabetic retinopathy. Vitreous surgery and advances in fundus diagnosis and treatment 1977, 297-313. Appleton-Century-Crofts, New York. H.M. Freeman, T. Hirose, C.L. Schepens (Eds.).
3. Aaberg TM, Abrams GW Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy. Ophthalmology 1987, 94:775-779.
4. Diabetic Retinopathy Study Research Group Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976, 81:383.
5. Henkind P Ocular neovascularization. The Krill memorial lecture. Am J Ophthalmol 1978, 85:287-301.
6. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994, 33l:1480-1487.
7. Frank RN, Amin RH, Eliott D, et al. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 1996, 122:393-403.
8. Frank RN, Amin R, Kennedy A, et al. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch Ophthalmol 1997, 115:1036-1047.
9. Meyer-Schwickerath R, Pfeiffer A, Blum WF, et al. Vitreous levels of insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease: studies in nondiabetic and diabetic subjects. J Clin Invest 1993, 92:2620-2625.
10. Sivalingam A, Kenney J, Brown GC, et al. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1990, 108:869-872.
11. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-450.
12. Ambati J, Chalam KV, Chawla DK, et al. Elevated γ-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1997, 115:1161-1166.
13. Grant M, Russell B, Fitzgerald C, et al. Insulin-like growth factors in vitreous: studies in control and diabetic subjects with neovascularization. Diabetes 1986, 35:416-420.
14. Funtatsu H, Yamashita H, Noma H, et al. Stimulation and inhibition of angiogenesis in diabetic retinopathy. Jpn J Ophthalmol 2001, 45:577-584.
15. Hernandez C, Burgos R, Canton A, et al. Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Care 2001, 24:516-521.
16. Nicoletti VG, Nicoletti R, Ferrara N, et al. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF). Exp Clin Endocrinol Diabetes 2003, 111:209-214.
17. Funatsu H, Yamashita H, Noma H, et al. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin. Invest Ophthalmol Vis Sci 2003, 44:1042-1047.
18. Deng J, Wu DZ, Gao R Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Yan Ke Xue Bao 1999, 15:17-21.
19. Simo R, Lecube A, Segura RM, et al. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Am J Ophthalmol 2002, 134:376-382.
20. Ogata N, Nishikawa M, Nishimura T, et al. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol 2002, 134:348-353.
21. Patel B, Hiscott P, Charteris D, et al. Retinal and preretinal localisation of epidermal growth factor. Transforming growth factor alpha, and their receptors in proliferative diabetic retinopathy. Br J Ophthalmol 1994, 78:714-718.
22. Vinores SA, Henderer ID, Mahlow J, et al. Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: immunolocalization to retinal pigmented epithelial cells. Exp Eye Res 1995, 60:607-619.
23. Malecaze F, Clamens S, Simorre-Pinatel V, et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994, 112:1476-1482.
24. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994, 145:574-584.
25. Pe'er I, Shweiki D, Itin A, et al. Hypoxia-induced expression of vascular endothelial growth factor (VEGF) by retinal cells is a common factor in neovascularization. Lab Invest 1995, 72:638-645.
26. Pierce EA, Avery RL, Foles ED, et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995, 92:905-909.
27. Schweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
28. Amin RH, Frank RN, Kennedy A, et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997, 38:36-47.
29. Murata T, Nakagawa K, Khalil A, et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 1996, 74:819-825.
30. Davis MD Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol 1965, 74:741.
31. Faulborn J, Bowald S Microproliferations in proliferative diabetic retinopathy and their relationship to the vitreous: corresponding light and microscopic studies. Graefes Arch Clin Exp Ophthalmol 1985, 223:130.
32. Abrams GW. Unpublished observation, 1999.
33. Eliott D Vitreoretinal attachments in proliferative diabetic retinopathy: effect on outcome. Vail vitrectomy meeting 2004, Vail, CO.
34. Le Mer Y, Korobelnik JF, Morel C, et al. TPA-assisted vitrectomy for proliferative diabetic retinopathy: results of a double-masked, multicenter trial. Retina 1999, 19:378-382.
35. Williams JG, Trese MT, Williams GA, et al. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology 2001, 108:1902-1905.
36. Brucker AJ, Michels RG, Green WR Pars plana vitrectomy in the management of blood-induced glaucoma with vitreous hemorrhage. Ann Ophthalmol 1978, 10:1427.
37. Campbell DG, Simmons RJ, Grant WM Ghost cells as a cause of glaucoma. Am J Ophthalmol 1976, 81:441.
38. Campbell DG, Simmons RJ, Tolentino FI, et al. Glaucoma occurring after closed vitrectomy. Am J Ophthalmol 1977, 83:63.
39. Weinberg RS, Peyman GA, Huamonte FU Elevation of intraocular pressure after pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 1976, 200:157.
40. Wilensky JT, Goldberg MF, Alward P Glaucoma after pars plana vitrectomy. Trans Am Acad Ophthalmol Otolaryngol 1977, 83:114.
41. Diabetic Retinopathy Vitrectomy Study Research Group Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management, Diabetic Retinopathy Vitrectomy Study report 1. Ophthalmology 1985, 92:492-502.
42. Diabetic Retinopathy Vitrectomy Study Research Group Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results of a randomized trial, Diabetic Retinopathy Vitrectomy Study report 2. Arch Ophthalmol 1985, 103:1644.
43. O'Hanley GP, Canny CLB Diabetic dense premacular hemorrhage: a possible indication for prompt vitrectomy. Ophthalmology 1985, 92:507-511.
44. Ramsay RC, Knobloch WH, Cantrill HL Timing of vitrectomy for active proliferative diabetic retinopathy. Ophthalmology 1986, 93:283.
45. Harbour JW, Smiddy WE, Flynn HW, et al. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 1996, 121:405-413.
46. Lewis H, Abrams GW, Blumenkranz MS, et al. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 1992, 99:753-759.
47. Rosenblatt BJ, Shah GK, Sharma S, et al. Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol Jul 2005, 243:20-25.
48. Kroll P, Wiegand W, Schmidt J Vitreopapillary traction in proliferative diabetic vitreoretinopathy. Br J Ophthalmol 1999, 83:261-264.
49. McLeod D Diabetic tractional papillopathy: a new (and true) nosological entity?. Br J Ophthalmol 1999, 83:257-258.
50. Diabetic Retinopathy Vitrectomy Study Research Group Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision: results of a randomized trial, Diabetic Retinopathy Vitrectomy Study report 3. Ophthalmology 1988, 95:1307.
51. Diabetic Retinopathy Vitrectomy Study Research Group Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision: clinical application of results of a randomized trial, Diabetic Retinopathy Vitrectomy Study report 4. Ophthalmology 1988, 95:1321.
52. Diabetic Retinopathy Vitrectomy Study Research Group Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: four-year results of a randomized trial, Diabetic Retinopathy Vitrectomy Study report 5. Arch Ophthalmol 1990, 108:958.
53. Machemer R Reminiscences after 25 years of pars plana vitrectomy. Am J Ophthalmol 1995, 119:505-510.
54. Machemer R The development of pars plana vitrectomy: a personal account. Graefes Arch Clin Exp Ophthalmol 1995, 233:453-468.
55. Machemer R, Blankenship G Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage. Ophthalmology 1981, 88:643.
56. Michels RG, Rice TA, Rice EF Vitrectomy for diabetic vitreous hemorrhage. Am J Ophthalmol 1983, 95:12.
57. Peyman GA, Huamonte FU, Goldberg MF, et al. Four hundred consecutive pars plana vitrectomies with the vitreophage. Arch Ophthalmol 1978, 96:45-50.
58. Peyman GA, Raichand M, Huamonte FU, et al. Vitrectomy in 125 eyes with diabetic vitreous hemorrhage. Br J Ophthalmol 1976, 60:752-755.
59. Thompson JT, de Bustros S, Michels RG, et al. Results and prognostic factors in vitrectomy for diabetic vitreous hemorrhage. Arch Ophthalmol 1987, 105:191.
60. Francois J, Cambie E Retinal photocoagulation (xenon arc and lasers). Ann Ophthalmol 1979, 3:1201-1208.
61. Friberg TR Clinical experience with a binocular indirect ophthalmoscope laser delivery system. Retina 1987, 7:28-31.
62. Friberg TR Principles of photocoagulation using binocular indirect ophthalmoscope laser delivery system. Int Ophthalmol Clin 1990, 30:89.
63. Whitacre MM, Manoukian N, Mainster MA Argon indirect ophthalmoscopic photocoagulation: reduced potential phototoxicity with a fixed safety filter. Br J Ophthalmol 1990, 74:233-234.
64. Gardner TW, Blankenship GW Proliferative diabetic retinopathy: principles and techniques of surgical treatment. Retina 1994, 515-539. Mosby, St. Louis. 2nd edn. S.J. Ryan (Ed.).
65. Charles S Endophotocoagulation. Retina 1981, 1:117-120.
66. Fleischman JA, Swartz M, Dixon JA Argon laser endophotocoagulation: an intraoperative trans-pars plana technique. Arch Ophthalmol 1981, 99:1610.
67. Landers MB, Trese MT, Stefansson E, et al. Argon laser intraocular photocoagulation. Ophthalmology 1982, 89:785.
68. Parke DW, Aaberg TM Intraocular argon laser photocoagulation in the management of severe proliferative vitreoretinopathy. Am J Ophthalmol 1984, 97:434-443.
69. Blankenship GW Preoperative prognostic factors in diabetic pars plana vitrectomy. Ophthalmology 1982, 89:1246.
70. Machemer R, Hickingbotham D The three-port microcannular system for closed vitrectomy. Am J Ophthalmol 1985, 100:590.
71. Thompson JT, Auer CL, de Bustros S, et al. Prognostic indicators of success and failure in vitrectomy for diabetic retinopathy. Ophthalmology 1986, 93:290.
72. Ho T, Smiddy WE, Flynn HW Vitrectomy in the management of diabetic eye disease. Surv Ophthalmol 1992, 37:190-202.
73. Aaberg TM Clinical results in vitrectomy for diabetic traction retinal detachment. Am J Ophthalmol 1979, 88:246-253.
74. Aaberg TM Pars plana vitrectomy for diabetic traction retinal detachment. Ophthalmology 1981, 88:639-642.
75. Charles S Vitrectomy for retinal detachment. Trans Ophthalmol Soc UK 1980, 100:542.
76. Hutton WL, Bernstein I, Fuller D Diabetic traction retinal detachment. Ophthalmology 1980, 87:1071.
77. Michels RG Vitrectomy for complications of diabetic retinopathy. Arch Ophthalmol 1978, 96:237.
78. Miller SA, Butler JB, Myers FL, et al. Pars plana vitrectomy: treatment for tractional macula detachment secondary to proliferative diabetic retinopathy. Arch Ophthalmol 1980, 98:659-664.
79. Packer AJ Vitrectomy for progressive macular traction associated with proliferative diabetic retinopathy. Arch Ophthalmol 1987, 105:1679-1683.
80. Ratner CM, Michels RG, Auer C, et al. Pars plana vitrectomy for complicated retinal detachments. Ophthalmology 1983, 90:1323.
81. Rice TA, Michels RG, Rice EF Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol 1983, 95:22-33.
82. Rice TA, Michels RG, Rice EF Vitrectomy for diabetic rhegmatogenous retinal detachment. Am J Ophthalmol 1983, 95:34.
83. Thompson JT, de Bustros S, Michels RG, et al. Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula. Arch Ophthalmol 1987, 105:497-502.
84. Tolentino FI, Freeman HM, Tolentino FL Closed vitrectomy in the management of diabetic traction retinal detachment. Ophthalmology 1980, 87:1078-1089.
85. Rice TA, Michels RG, Rice EF Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol 1983, 95:22-33.
86. Charles S, Flinn CE The natural history of diabetic extramacular traction retinal detachment. Arch Ophthalmol 1981, 99:66-68.
87. Cohen HB, McMeel JW, Franks EP Diabetic traction detachment. Arch Ophthalmol 1979, 97:1268.
88. Spencer R, McMeel JW, Franks EP Visual outcome in moderate and severe proliferative diabetic retinopathy. Arch Ophthalmol 1981, 99:1551.
89. Blankenship G, Machemer R, Mandelcorn M Pars plana vitrectomy for the management of severe diabetic retinopathy. Am J Ophthalmol 1976, 81:561-570.
90. Charles S Clinical applications of vitreoretinal surgery - the ocutome system. Highlights Ophthalmol 1980, 16:178-216.
91. Bresnick GH, Haight B, de Venecia G Retinal wrinkling and macular heterotopia in diabetic retinopathy. Arch Ophthalmol 1979, 97:1890-1895.
92. Bresnick GH, Smith V, Pokorny J Visual function abnormalities in macular heterotopia caused by proliferative diabetic retinopathy. Am J Ophthalmol 1981, 92:85-102.
93. Michael JC, de Venecia G, Bresnick GH Macular heterotopia in proliferative diabetic retinopathy. Arch Ophthalmol 1994, 112:1455-1459.
94. Blankenship GW Posterior retinal holes secondary to diabetic retinopathy. Arch Ophthalmol 1983, 101:885.
95. Gragoudas ES, McMeel JW Treatment of rhegmatogenous retinal detachment secondary to proliferative diabetic retinopathy. Am J Ophthalmol 1976, 81:810.
96. Morse LS, Chapman CB, Eliott D, et al. Subretinal hemorrhages in proliferative diabetic retinopathy. Retina 1997, 17:87-93.
97. Federman JL, Schubert HD Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology 1988, 95:870.
98. Gonvers M Temporary silicone oil tamponade in the treatment of complicated diabetic retinal detachments. Graefes Arch Clin Exp Ophthalmol 1990, 228:415.
99. Heimann K, Dahl B, Dimopoulos S, et al. Pars plana vitrectomy and silicone oil injection in proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1989, 227:152.
100. Oldendoerp J, Spitznas M Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus. Graefes Arch Clin Exp Ophthalmol 1989, 227:1.
101. Wilson-Holt N, Leaver PK Extended criteria for vitrectomy and fluid/silicone oil exchange. Eye 1990, 4:850.
102. Yeo JH, Glaser BM, Michels RG Silicone oil in the treatment of complicated retinal detachments. Ophthalmology 1987, 94:1109.
103. Thompson JT, de Bustros S, Michels RG, et al. Results and prognostic factors in vitrectomy for diabetic traction-rhegmatogenous retinal detachment. Arch Ophthalmol 1987, 105:503.
104. Blankenship GW, Machemer R Prophylactic vitrectomy in proliferative diabetic retinopathy. Mod Probl Ophthalmol 1977, 18:236.
105. Blankenship GW, Machemer R Long-term diabetic vitrectomy results: report of 10-year follow-up. Ophthalmology 1985, 92:503-506.
106. de Bustros S, Thompson JT, Michels RG, et al. Vitrectomy for progressive proliferative diabetic retinopathy. Arch Ophthalmol 1987, 105:196.
107. Rice TA, Michels RG Long-term anatomic and functional results of vitrectomy for diabetic retinopathy. Am J Ophthalmol 1980, 90:297.
108. Schachat AP, Oyakawa RT, Michels RG, et al. Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology 1983, 90:522.
109. Schimek RA, Spencer R Cryopexy treatment for proliferative diabetic retinopathy: retinal cryoablation in patients with severe vitreous hemorrhage. Arch Ophthalmol 1979, 97:1276.
110. Eliott D. Outcome of vitrectomy for dense, premacular, subhyaloid hemorrhage secondary to proliferative diabetic retinopathy. In: Retina Society/Vitreous Society annual meeting - the combined meeting. San Francisco, CA: 2002.
111. Faulborn J Behandlung einer diabetischen preaemaculaeren Blutung mit dem Q-switched neodymium:YAG laser. Spektrum Augenheilkd 1998, 2:33-35.
112. Gabel VP, Birngruber R, Gunther-Koszka H, et al. Nd:YAG laser photodisruption of hemorrhagic detachment of the internal limiting membrane. Am J Ophthalmol 1989, 107:33-37.
113. Raymond LA Neodymium:YAG laser treatment for hemorrhages under the internal limiting membrane and posterior hyaloid face in the macula. Ophthalmology 1995, 102:406-411.
114. Ulbig MW, Mangouritsas G, Rothbacher HH, et al. Long-term results after drainage of premacular subhyaloid hemorrhage into the vitreous with a pulsed Nd:YAG laser. Arch Ophthalmol 1998, 116:1465-1469.
115. Celebi S, Kukner AS Photodisruptive Nd:YAG laser in the management of premacular subhyaloid hemorrhage. Eur J Ophthalmol 2001, 11:281-286.
116. Puthalath S, Chirayath A Shermila MV et al. Frequency-doubled Nd:YAG laser treatment for premacular hemorrhage. Ophthalmic Surg Lasers Imaging 2003, 34:284-290.
117. Ezra E, Dowler JGF, Burgess F, et al. Identifying maculopathy after neodymium:YAG membranotomy for dense diabetic premacular hemorrhage. Ophthalmology 1996, 103:1568-1574.
118. Nasrallah FP, Jalkh AE, Van Coppenolle F, et al. The role of the vitreous in diabetic macular edema. Ophthalmology 1988, 95:1335-1339.
119. Hikichi T, Fujio N, Akiba J, et al. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 1997, 104:473-478.
120. Tachi N, Ogino N Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 1996, 122:258-260.
121. Ghartey KN, Tolentino FL, Freeman HM Closed vitreous surgery. XVII. Results and complications of pars plana vitrectomy. Arch Ophthalmol 1980, 98:1248-1252.
122. Han DP, Lewis H, Lambrou FH, et al. Mechanisms of intraocular pressure elevation after pars plana vitrectomy. Ophthalmology 1989, 96:1357.
123. Singh H, Grand MG Treatment of blood-induced glaucoma by trans pars plana vitrectomy. Retina 1981, 1:255-257.
124. Blankenship G Preoperative iris rubeosis and diabetic vitrectomy results. Ophthalmology 1980, 87:176.
125. Little HL, Rosenthal AR, Dellaporta A, et al. The effect of pan-retinal photocoagulation on rubeosis iridis. Am J Ophthalmol 1976, 81:804.
126. Michels RG Vitreoretinal and anterior segment surgery through the pars plana. I. Ann Ophthalmol 1976, 8:1353-1381.
127. Michels RG, Stark WJ Vitrectomy technique in anterior segment surgery. Trans Am Acad Ophthalmol Otolaryngol 1976, 81:382.
128. Murray TG, Boldt HC, Lewis H, et al. A technique for facilitated visualization and dissection of the vitreous base, pars plana, and pars plicata. Arch Ophthalmol 1991, 109:145.
129. Pavan PR, Folk JC, Weingeist TA, et al. Diabetic rubeosis and panretinal photocoagulation: a prospective, controlled, masked trial using iris fluorescein angiography. Arch Ophthalmol 1983, 101:882.
130. Wand M, Dueker DK, Aiello LM, et al. Effects of pan-retinal photocoagulation of rubeosis iridis, angle neovascularization, and neovascular glaucoma. Am J Ophthalmol 1978, 86:332.
131. Lloyd MA, Heuer DK, Baerveldt G, et al. Combined molteno implantation and pars plana vitrectomy for neovascular glaucomas. Ophthalmology 1991, 98:1401.
132. Luttrell JK, Avery RL Pars plana implant and vitrectomy for treatment of neovascular glaucoma. Retina 1995, 15:379-387.
133. Ramsay RC, Cantrill HL, Knobloch WH Cryoretinopexy for proliferative diabetic retinopathy. Can J Ophthalmol 1982, 17:17-20.
134. Sihota R, Sandramouli S, Sood NN A prospective evaluation of anterior retinal cryoablation in neovascular glaucoma. Ophthalm Surg 1991, 22:256-259.
135. Allen RC, Bellows AR, Hutchinson BT, et al. Filtration surgery in the treatment of neovascular glaucoma. Ophthalmology 1982, 89:1181-1187.
136. Flaxel CJ, Larkin GB, Broadway DB, et al. Peripheral transscleral retinal diode laser for rubeosis iridis. Retina 1997, 17:421-429.
137. Tsai JC, Bloom PA, Franks WA, et al. Combined trans-scleral diode laser cyclophotocoagulation and transscleral retinal photocoagulation for refractory neovascular glaucoma. Retina 1996, 16:164-166.
138. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
139. Diabetes Control and Complications Trial Research Group Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology 1995, 102:647-661.
140. Reichard P, Nilsson BY, Rosenqvist U The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993, 329:304-309.
141. Shea M Early vitrectomy in proliferative diabetic retinopathy. Arch Ophthalmol 1983, 101:1204.
142. Ehrenberg M, McCuen BW, Schindler RH, et al. Rubeosis iridis: preoperative iris fluorescein angiography and periocular steroids. Ophthalmology 1984, 91:321.
143. Zakov ZN, Lewis ML Iris fluorescein angiography in diabetic vitrectomy patients. Graefes Arch Clin Exp Ophthalmol 1978, 206:17.
144. Blumenkranz MS, Frazier Byrne S Standardized echography (ultrasonography) for the detection and characterization of retinal detachment. Ophthalmology 1982, 89:821.
145. Coleman DJ Preoperative evaluation of the vitreous with ultrasound. New and controversial aspects of vitreoretinal surgery 1977, 95-102. Mosby, St. Louis. A. McPherson (Ed.).
146. Ossoinig KC, Frazier SL, Watzke RC, et al. Combined A-scan and B-scan echography as a diagnostic aid for vitreoretinal surgery. New and controversial aspects of vitreo-retinal surgery 1977, 106-125. Mosby, St. Louis. A. McPherson (Ed.).
147. Purnell EW, Frank KE, Cappaert WE Preoperative ultrasonographic evaluation of vitrectomy candidates with diabetic retinopathy. New and controversial aspects of vitreoretinal surgery 1977, 84-94. Mosby, St. Louis. A. McPherson (Ed.).
148. Fuller DG, Hutton WL Presurgical evaluation of eyes with opaque media 1982, Grune & Stratton, New York.
149. Fuller DG, Knighton RW, Machemer R Bright-flash electroretinography for the evaluation of eyes with opaque vitreous. Am J Ophthalmol 1975, 80:214.
150. Hutton WL, Fuller DG Factors influencing final visual results in severely injured eyes. Am J Ophthalmol 1984, 97:715.
151. Mandelbaum S, Cleary PE, Ryan SJ, et al. Bright-flash electroretinography and vitreous hemorrhage: an experimental study in primates. Arch Ophthalmol 1980, 98:1823.
152. Scherfig E, Edmund J, Tinning S, et al. Flash visual evoked potential as a prognostic factor for vitreous operations in diabetic eyes. Ophthalmology 1984, 91:1475.
153. Fu AD, McDonald HR, Eliott D, et al. Complications of general anesthesia using nitrous oxide in eyes with preexisting gas bubbles. Retina 2002, 22:569-574.
154. Benson WE, Diamond JG, Tasman W Intraocular irrigating solutions for pars plana vitrectomy. Arch Ophthalmol 1981, 99:1013.
155. Edelhauser HE, Gonnering R, Van Horn DL Intraocular irrigating solutions: a comparative study of BSS Plus and lactated Ringer's solution. Arch Ophthalmol 1978, 96:516.
156. Edelhauser HF, Van Horn DL, Schultz RO, et al. Comparative toxicity of intraocular irrigating solutions on the corneal endothelium. Am J Ophthalmol 1976, 81:473.
157. Haimann MH, Abrams GW Prevention of lens opacification during diabetic vitrectomy. Ophthalmology 1984, 91:116.
158. Rosenfeld SI, Waltman SR, Olk J, et al. Comparison of intraocular irrigating solutions in pars plana vitrectomy. Ophthalmology 1986, 93:109.
159. Waltman SR, Carroll D, Schimmelpfennig W, et al. Intraocular irrigating solutions for clinical vitrectomy. Ophthalm Surg 1975, 6:90.
160. Hull DS, Chemotti MT, Edelhauser HF, et al. Effect of epinephrine on the corneal endothelium. Am J Ophthalmol 1975, 79:245.
161. Morgan BS, Larson B, Peyman GA, et al. Toxicity of antibiotic combinations for vitrectomy infusion fluid. Ophthalm Surg 1979, 10:74.
162. de Bustros S, Glaser BM, Johnson MA Thrombin infusion for the control of intraocular bleeding during vitreous surgery. Arch Ophthalmol 1985, 103:837.
163. Thompson JT, Glaser BM, Michels RG, et al. The use of intravitreal thrombin to control hemorrhage during vitrectomy. Ophthalmology 1986, 93:279.
164. Johnson RN, Blankenship G A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin. Ophthalmology 1988, 95:312.
165. Blankenship GW Evaluation of a single intravitreal injection of dexamethasone phosphate in vitrectomy surgery for diabetic retinopathy complications. Graefes Arch Clin Exp Ophthalmol 1991, 229:62.
166. Blankenship GW Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases. Graefes Arch Clin Exp Ophthalmol 1989, 227:565.
167. Jabbour NM, Schepens CL, Buzney SM Local ocular hypothermia in experimental intraocular surgery. Ophthalmology 1988, 95:1687-1690.
168. Zilis JD, Chandler D, Machemer R Clinical and histologic effects of extreme intraocular hypothermia. Am J Ophthalmol 1990, 190:469.
169. de Juan E, Landers MB, Hickingbotham D An improved contact-lens holder for vitreous surgery. Am J Ophthalmol 1985, 99:213.
170. Landers MB, Stefansson E, Wolbarsht ML The optics of vitreous surgery. Am J Ophthalmol 1981, 91:611.
171. Machemer R A new concept for vitreous surgery. VII. Two instrument techniques in pars plana vitrectomy. Arch Ophthalmol 1974, 92:407.
172. Machemer R, Aaberg TM Vitrectomy 1979, Grune & Stratton, New York. 2nd edn.
173. O'Malley C Viewing and illumination during intraocular surgery. Vitreous surgery and advances in fundus diagnosis and treatment 1977, 159-163. Appleton-Century-Crofts, New York. H.M. Freeman, T. Hirose, C.L. Schepens (Eds.).
174. Tolentino FL, Freeman HM, Schepens CL Observation and illumination system for closed vitreous surgery. Vitreous surgery and advances in fundus diagnosis and treatment 1977, Appleton-Century Crofts, New York. H.M. Freeman, T. Hirose, C.L. Schepens (Eds.).
175. Garcia-Valenzuela E, Abdelsalam A, Eliott D, et al. Reduced need for corneal epithelial debridement during vitreoretinal surgery using two different viscous surface lubricants. Am J Ophthalmol 2003, 136:1062-1066.
176. Lesnoni G, Billi B, Rossi T, et al. The use of panoramic viewing system in relaxing retinotomy and retinectomy. Retina 1997, 17:186-190.
177. Machemer R, Parel JM, Buettner H A new concept for vitreous surgery. I. Instrumentation. Am J Ophthalmol 1972, 73:1.
178. Thompson JT, de Bustros S, Michels RG, et al. Results of vitrectomy for proliferative diabetic retinopathy. Ophthalmology 1986, 93:1571.
179. Parel JM The VISC and the vitreomicroscope. New and controversial aspects of vitreoretinal surgery 1977, 129-138. Mosby, St. Louis. A. McPherson (Ed.).
180. Aaberg TM, Machemer R Vitreous band surgery: instrumentation and technique. Arch Ophthalmol 1972, 87:542.
181. de Juan E, Hickingbotham D Refinements in microinstrumentation for vitreous surgery. Am J Ophthalmol 1990, 109:218.
182. Douvas NG Microsurgical roto-extractor instrument for vitrectomy. Mod Probl Ophthalmol 1975, 15:253.
183. Federman JL, Cook K, Bross R, et al. Intraocular microsurgery. I. New instrumentation (SITE). Ophthalm Surg 1976, 7:82.
184. Kioti R Vitrektomie. I. Ein neues instrument fur die hintere vitrektomie. Graefes Arch Klin Ophthalmol 1973, 187:161.
185. O'Malley C, Heintz RM Vitrectomy with an alternative instrument system. Ann Ophthalmol 1975, 7:585.
186. O'Malley C, Tripp RM Plugs and stiletto: entry incisions for a 20-gauge instrument system. Ophthalm Surg 1977, 8:76.
187. Peyman GA, Dodich NA Experimental vitrectomy: instrumentation and surgical technique. Arch Ophthalmol 1971, 86:548.
188. Tolentino FL, Banko A, Schepens CL, et al. Vitreous surgery. XII. New instrumentation for vitrectomy. Arch Ophthalmol 1975, 93:667.
189. Charles S, Wang C A linear suction control for the vitreous cutter (ocutome). Arch Ophthalmol 1981, 99:1613.
190. Benson WE, Blankenship GW, Machemer R Pars plana lens removal with vitrectomy. Am J Ophthalmol 1977, 84:150.
191. Benson WE, Brown GC, Tasman W, et al. Extracapsular cataract extraction, posterior chamber lens insertion, and pars plana vitrectomy in one operation. Ophthalmology 1990, 97:918.
192. Blankenship GW Posterior chamber intraocular lens implantation during pars plana lensectomy and vitrectomy for diabetic complications. Graefes Arch Clin Exp Ophthalmol 1989, 227:136.
193. Blankenship GW, Flynn HW, Kokame GT Posterior chamber intraocular lens insertion during pars plana lensectomy and vitrectomy for complications of proliferative diabetic retinopathy. Am J Ophthalmol 1989, 108:1.
194. Coleman DJ Phakoemulsification with vitrectomy through the pars plana. Ophthalm Surg 1975, 6:95.
195. Koenig SB, Han DP, Mieler WF, et al. Combined phacoemulsification and pars plana vitrectomy. Arch Ophthalmol 1990, 108:362.
196. Koenig SB, Mieler WF, Han DP, et al. Combined phacoemulsification, pars plana vitrectomy, and posterior chamber intraocular lens insertion. Arch Ophthalmol 1992, 110:1101.
197. Kokame GT, Flynn HW, Blankenship GW Posterior chamber intraocular lens implantation during diabetic pars plana vitrectomy. Ophthalmology 1989, 96:603.
198. Machemer R Cataract extraction in cases of cataract with vitreous abnormality. Ophthalmology 1980, 87:618.
199. Peyman GA, Huamonte F, Goldberg MF Management of cataract in patients undergoing vitrectomy. Am J Ophthalmol 1975, 80:30.
200. Ruiz RS, Saatci OA Posterior chamber intraocular lens implantation in eyes with inactive and active proliferative diabetic retinopathy. Am J Ophthalmol 1991, 111:158.
201. Parel JM, Machemer R, Aumayr W A new concept for vitreous surgery. IV. Improvements in instrumentation and illumination. Am J Ophthalmol 1974, 77:161.
202. Michels M, Sidikaro Y Shadow and reflex-free use of combined fiberoptic manipulators and illuminators in vitreous surgery. Am J Ophthalmol 1990, 109:358.
203. Ryan EH An illuminated cannula for viscodelamination. Arch Ophthalmol 1989, 107:1085.
204. Flynn HW, Brod RD Protection from operating microscope-induced retinal phototoxicity during pars plana vitrectomy. Arch Ophthalmol 1988, 106:1032.
205. McDonald HR, Harris MJ Operating microscope-induced retinal phototoxicity during pars plana vitrectomy. Arch Ophthalmol 1988, 106:521.
206. Charles S Bipolar bimanual diathermy. Arch Ophthalmol 1981, 99:1868. (letter).
207. Charles S, White J, Dennison C, et al. Bimanual bipolar intraocular diathermy. Am J Ophthalmol 1976, 81:101.
208. Davidorf FH, Chambers RB, Reimels HG Evacuation/cautery vitreous needle. Arch Ophthalmol 1989, 107:607.
209. Machemer R Transvitreal radiofrequency diathermy. Am J Ophthalmol 1977, 83:282.
210. McCuen BW, Hickingbotham D A fiberoptic diathermy tissue manipulator for use in vitreous surgery. Am J Ophthalmol 1984, 98:803.
211. Schepens CL Transvitreal radiofrequency diathermy. Am J Ophthalmol 1978, 85:574.
212. Schepens CL, Delori F, Rogers FJ, et al. Optimized underwater diathermy for vitreous surgery. Ophthalm Surg 1975, 6:82.
213. Tate GW, Hutton WL, Vaiser A, et al. A coaxial electrode for intraocular diathermy. Am J Ophthalmol 1975, 79:691.
214. Irvine WD, Smiddy WE, Nicholson DH Corneal and iris burns with the laser indirect ophthalmoscope. Am J Ophthalmol 1990, 110:311.
215. Michels RG Vitreous surgery. St 1981, Mosby, Louis.
216. Charles S, Wang C A motorized gas injector for vitreous surgery. Arch Ophthalmol 1981, 99:1398.
217. Danis RP, Thompson JT Flow dynamics of extrusion needle vacuuming in a closed vitrectomy system. Arch Ophthalmol 1990, 108:267.
218. Flynn HW, Blumenkranz MS, Parel JM, et al. Cannulated subretinal fluid aspirator for vitreoretinal microsurgery. Am J Ophthalmol 1987, 103:106.
219. Michels M, Sidikaro Y A new instrument for ab interno drainage of subretinal fluid. Am J Ophthalmol 1990, 109:360.
220. Isbey EK, Hickingbotham D, Landers MB New scleral plugs for use during vitrectomy. Am J Ophthalmol 1981, 91:797.
221. Territo C, Gieser JP, Wilson CA, et al. Influence of the cannulated vitrectomy system on the occurrence of iatrogenic sclerotomy retinal tears. Retina 1997, 17:430-433.
222. Machemer R, Parel JM, Hickingbotham D, et al. Membrane peeler cutter: automated vitreous scissors and hooked needle. Arch Ophthalmol 1981, 99:152.
223. Han DP, Abrams GW, Aaberg TM Surgical excision of the attached posterior hyaloid. Arch Ophthalmol 1988, 106:998.
224. Machemer R Vitrectomy in diabetic retinopathy removal of preretinal proliferations. Trans Am Acad Ophthalmol Otolaryngol 1975, 79:394.
225. Michels RG Vitrectomy for diabetic retinopathy: pathophysiology of extraretinal complications and principles of vitreous surgery. Retina 1981, 1:1.
226. Williams GA, Abrams GW, Mieler WF Illuminated retinal picks for vitreous surgery. Arch Ophthalmol 1989, 107:1086.
227. Hueneke RL, Aaberg TM Instrumentation for continuous fluid-air exchange during vitreous surgery. Am J Ophthalmol 1983, 96:547.
228. Kieiner RC A new device for performing fluid-gas exchanges. Arch Ophthalmol 1988, 106:421.
229. McCuen BW, Bessler M, Hickingbotham D, et al. Automated fluid-gas exchange. Am J Ophthalmol 1983, 95:717.
230. Abrams GW, Edelhauser HE, Aaberg TM, et al. Dynamics of intravitreal sulfur hexafluoride gas. Invest Ophthalmol 1974, 13:863.
231. Chang S, Lincoff HA, Coleman DJ, et al. Perfluorocarbon gases in vitreous surgery. Ophthalmology 1985, 92:651.
232. Fineberg E, Machemer R, Sullivan P, et al. Sulfur hexafluoride in owl monkey vitreous cavity. Am J Ophthalmol 1975, 79:67.
233. Lincoff H, Mardirossian J, Lincoff A, et al. Intravitreal longevity of three perfluorocarbon gases. Arch Ophthalmol 1980, 98:1610.
234. Norton EWD Intraocular gas in the management of selected retinal detachments. Am J Ophthalmol 1973, 77:85.
235. Norton EWD, Fuller DG The use of intraocular sulfur hexafluoride in vitrectomy. Advances in vitreous surgery 1976, 535-542. Charles C Thomas, Springfield, IL. A.R. Irvine, C. O'Malley (Eds.).
236. Thompson JT Kinetics of intraocular gases, disappearance of air, sulfur hexafluoride, and perfluoropropane after pars plana vitrectomy. Arch Ophthalmol 1989, 107:687.
237. Azzolini C, Brancato R, Camesasca FL, et al. Influence of silicone oil on iris microangiopathy in diabetic vitrectomized eyes. Ophthalmology 1993, 100:1152-1159.
238. Brourman ND, Blumenkranz MS, Cox MS, et al. Silicone oil for the treatment of severe proliferative diabetic retinopathy. Ophthalmology 1989, 96:759.
239. Gnad H, Skorpik C, Paroussis P, et al. Temporare silikonol-implantatoin bei proliferativer diabetischer retinopathie. Klin Monatsbl Augenheilkd 1986, 189:388.
240. Lucke KH, Foerster MH, Laqua H Long-term results of vitrectomy and silicone oil in 500 cases of complicated retinal detachments. Am J Ophthalmol 1987, 104:624.
241. McCuen BW, Rinkoff JS Silicone oil for progressive anterior ocular neovascularization after failed diabetic vitrectomy. Arch Ophthalmol 1989, 107:677-683.
242. McLeod D Silicone oil injection during closed microsurgery for diabetic retinal detachment. Graefes Arch Clin Exp Ophthalmol 1986, 224:55.
243. Riedel KG, Gabel VP, Neubauer L, et al. Intravitreal silicone oil injection: complications and treatment of 415 consecutive patients. Graefes Arch Clin Exp Ophthalmol 1990, 228:19.
244. Rinkoff JS, de Juan E, McCuen BW Silicone oil for retinal detachment with advanced proliferative vitreoretinopathy following failed vitrectomy for proliferative diabetic retinopathy. Am J Ophthalmol 1986, 101:181.
245. Stirpe M, Orciulo M Pneumatic syringe used in fibrovascular membrane surgery. Am J Ophthalmol 1985, 99:729.
246. Blankenship GW Implantation of an intraocular lens during diabetic vitrectomy. Medical and surgical retina: advances, controversies, and management 1994, 321-325. Mosby, St. Louis. H. Lewis, S.J. Ryan (Eds.).
247. Foster RE, Lowder CY, Meisler DM, et al. Combined extracapsular cataract extraction, posterior chamber intraocular lens implantation, and pars plana vitrectomy. Ophthalm Surg 1993, 24:446-452.
248. Douglas MJ, Scott IV, Flynn HW Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy. Ophthalm Surg Lasers Imaging 2003, 34:270-278.
249. Lahey JM, Francis RR, Kearney JJ Combining phacoemulsification with pars plana vitrectomy in patients with proliferative diabetic retinopathy: a series of 223 cases. Ophthalmology 2003, 110:1335-1339.
250. Kim SH, Chung JW, Chung H, et al. Phacoemulsification and foldable intraocular lens implantation combined with vitrectomy and silicone oil tamponade for severe proliferative diabetic retinopathy. J Cataract Refract Surg 2004, 30:1721-1726.
251. Menchini U, Azzolini C, Camesasea FL, et al. Combined vitrectomy, cataract extraction, and posterior chamber intraocular lens implantation in diabetic patients. Ophthalm Surg 1991, 22:69-73.
252. Meredith TA, Kaplan HJ, Aaberg TM Pars plana vitrectomy techniques for relief of epiretinal traction by membrane segmentation. Am J Ophthalmol 1980, 89:408.
253. Charles S Vitreous microsurgery 1987, Williams & Wilkins, Baltimore, MD. 3rd edn.
254. Abrams GW En bloc dissection techniques in vitrectomy for diabetic retinopathy. Medical and surgical retina: advances, controversies, and management 1994, 304-320. Mosby, St. Louis. H. Lewis, S.J. Ryan (Eds.).
255. Abrams GW, Williams GA "En bloc" excision of diabetic membranes. Am J Ophthalmol 1987, 103:302.
256. Han DP, Murphy ML, Mieler WF A modified en bloc excision technique during vitrectomy for diabetic traction retinal detachment: results and complications. Ophthalmology 1994, 101:803-808.
257. Williams DF, Williams GA, Hartz A, et al. Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision technique. Ophthalmology 1989, 96:752-758.
258. Pendergast SD, Martin DF, Proia AD, et al. Removal of optic disc stalks during diabetic vitrectomy. Retina 1995, 15:25-28.
259. McLeod D, James CR Viscodelamination at the vitreoretinal juncture in severe diabetic eye disease. Br J Ophthalmol 1988, 72:413.
260. Packer AJ, Folk JC, Weingesit TA, et al. Procoagulant effects of intraocular sodium hyaluronate. Am J Ophthalmol 1985, 100:479.
261. Stenkula S, Ivert L Sodium hyaluronate (Healon) as an intravitreal aid in retinal and vitreous surgery. J Ocular Ther Surg 1984, 3:109.
262. Byrne SF, Green RL Ultrasound of the eye and orbit 1992, Mosby, St Louis.
263. Chu TG, Lopez PF, Cano MR, et al. Posterior vitreoschisis: an echographic finding in proliferative diabetic retinopathy. Ophthalmology 1996, 103:315-322.
264. Green RL, Byrne SF Diagnostic ophthalmic ultrasound. Retina 1994, 191-273. Mosby, St. Louis. 2nd edn. S.J. Ryan (Ed.).
265. Schwartz SD, Alexander R, Hiscott P, et al. Recognition of vitreoschisis in proliferative diabetic retinopathy: a useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology 1996, 103:323-328.
266. Kishi S, Shimizu K Clinical manifestations of posterior precortical vitreous pocket in proliferative diabetic retinopathy. Ophthalmology 1993, 100:225-229.
267. Friedman R Scleral depression to facilitate endophotocoagulation. Arch Ophthalmol 1988, 106:721.
268. Benedett R, Olk RJ, Arribas NP, et al. Transconjunctival anterior retinal cryotherapy for proliferative diabetic retinopathy. Ophthalmology 1987, 94:612.
269. Daily MJ, Gieser RG Treatment of proliferative diabetic retinopathy with panretinal cryotherapy. Ophthalm Surg 1984, 15:741.
270. Shimizu K, Kobayashi Y, Muraoka K Midperipheral fundus involvement in diabetic retinopathy. Ophthalmology 1981, 88:601.
271. Kreiger AE The pars plana incision: experimental studies, pathologic observations, and clinical experience. Trans Am Ophthalmol Soc 1991, 89:549.
272. Kreiger AE Wound complications in pars plana vitrectomy. Retina 1993, 13:335-344.
273. Krieger AE, Straatsma BR, Foos RY Incisional complications in pars plana vitrectomy. Mod Probl Ophthalmol 1977, 18:210.
274. Smith RB, Carl B, Linn JG, et al. Effect of nitrous oxide on air in vitreous. Am J Ophthalmol 1974, 78:314.
275. McDermott ML, Puklin JE, Abrams GW, et al. Phacoemulsification for cataract following pars plana vitrectomy. Ophthalm Surg Lasers 1997, 28:558-564.
276. Han DP, Pulido JS, Mieler WF, et al. Vitrectomy for proliferative diabetic retinopathy with severe equatorial fibrovascular proliferation. Am J Ophthalmol 1995, 119:563-570.
277. Lewis JM, Eliott D, Townsend-Pico W, et al. The indications and results of use of scleral buckling during vitrectomy for proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997, 38:483.
278. Eliott D, Lewis JM, Townsend-Pico W, et al. Relaxing retinotomy performed during vitrectomy for proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997, 38:483.
279. Brightbill FS, Myers FL, Bresnick GH Postvitrectomy keratopathy. Am J Ophthalmol 1978, 85:651.
280. Faulborn J, Conway BP, Machemer R Surgical complications of pars plana vitreous surgery. Ophthalmology 1978, 85:116.
281. Foulks GN, Thoft RA, Perry HD, et al. Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch Ophthalmol 1979, 97:1076.
282. Oyakawa RT, Schachat AP, Michels RG, et al. Complications of vitreous surgery for diabetic retinopathy. I. Intraoperative complications. Ophthalmology 1983, 90:517.
283. Perry HD, Foulks GN, Thoft RA, et al. Corneal complications after closed vitrectomy through the pars plana. Arch Ophthalmol 1978, 96:1401.
284. Fuller DG, Wilson DL Translimbal iris hook for pupillary dilation during vitreous surgery. Am J Ophthalmol 1990, 110:577.
285. Packer AJ, McCuen BW, Hutton WL, et al. Procoagulant effects of intraocular sodium hyaluronate (Healon) after phakic diabetic vitrectomy. Ophthalmology 1989, 96:1491.
286. Brockhurst RJ Complications of closed vitrectomy. Vitreous surgery and advances in fundus diagnosis and treatment 1977, Appleton-Century-Crofts, New York. H.M. Freeman, T. Hirose, C.L. Schepens (Eds.).
287. Carter JB, Michels RG, Glaser BM, et al. Iatrogenic retinal breaks complicating pars plana vitrectomy. Ophthalmology 1980, 97:848.
288. Moura R Retinal detachment following vitrectomy. New and controversial aspects of vitreoretinal surgery. St 1977, Mosby, Louis. A. McPherson (Ed.).
289. del Priore LV, Michels RG, Nunez MA, et al. Intraocular pressure measurement after pars plana vitrectomy. Ophthalmology 1989, 96:1353.
290. Poliner LS, Schoch LH Intraocular pressure assessment in gas-filled eyes following vitrectomy. Arch Ophthalmol 1987, 105:200.
291. Kangas TA, Bennett SR, Flynn HW, et al. Reversible loss of light perception after vitreoretinal surgery. Am J Ophthalmol 1995, 120:751-756.
292. Barondes MJ, Davis MD, Myers FL Acute glaucoma following fluid-gas exchange in a phakic patient. Am J Ophthalmol 1989, 108:738.
293. Jaffe GJ, Abrams GW, Williams GA, et al. Tissue plasminogen activator for postvitrectomy fibrin formation. Ophthalmology 1990, 97:184.
294. Jaffe GJ, Lewis H, Han DP, et al. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator. Am J Ophthalmol 1989, 108:170.
295. Jaffe GJ, Schwartz D, Han DP, et al. Risk factors for postvitrectomy fibrin formation. Am J Ophthalmol 1990, 109:661.
296. Hiraoka M, Amano S, Oshika T, et al. Factors contributing to corneal complications after vitrectomy in diabetic patients. Jpn J Ophthalmol 2001, 45:492-495.
297. Azar DT, Spurr-Michaud SJ, Tisdale AS, et al. Decreased penetration of anchoring fibrils into the diabetic stroma: a morphometric analysis. Arch Ophthalmol 1989, 107:1520.
298. Chung H, Tolentino FI, Cajita VN, et al. Reevaluation of corneal complications after closed vitrectomy. Arch Ophthalmol 1988, 106:916.
299. Hyndiuk RA, Kazarian EL, Schultz RO, et al. Neurotrophic corneal ulcers in diabetes mellitus. Arch Ophthalmol 1977, 95:2193.
300. Kenyon KR Recurrent corneal erosion: pathogenesis and therapy. Int Ophthalmol Clin 1979, 19:169.
301. Snip RC, Thoft RA, Tolentino FL Similar epithelial healing rates of the corneas of diabetic and nondiabetic patients. Am J Ophthalmol 1980, 90:463.
302. Blankenship G, Cortez R, Machemer R The lens and pars plana vitrectomy for diabetic retinopathy complications. Arch Ophthalmol 1979, 97:1263.
303. Blankenship GW The lens influence on diabetic vitrectomy results: report of a prospective randomized study. Arch Ophthalmol 1980, 98:2196.
304. Hutton WL, Pesicka GA, Fuller DG Cataract extraction in the diabetic eye after vitrectomy. Am J Ophthalmol 1987, 104:1.
305. Michels RG Vitreous surgery for macular pucker. Am J Ophthalmol 1981, 92:628.
306. Novak MA, Rice TA, Michels RG, et al. The crystalline lens after vitrectomy for diabetic retinopathy. Ophthalmology 1984, 91:1480-1484.
307. Smiddy WE, Stark WJ, Michels RG, et al. Cataract extraction after vitrectomy. Ophthalmology 1987, 94:483.
308. Smiddy WE, Feuer W Incidence of cataract extraction after diabetic vitrectomy. Retina 2004, 24:574-581.
309. Apple DJ, Federman JL, Krolicki TJ, et al. Irreversible silicone oil adhesion to silicone intraocular lenses: a clinicopathological analysis. Ophthalmology 1996, 103:1555.
310. Eaton AM, Jaffe GJ, McCuen BW, et al. Condensation on the posterior surface of silicone intraocular lenses during fluid-air exchange. Ophthalmology 1995, 102:733.
311. Khawly JA, Lambert RJ, Jaffe GJ Intraocular lens changes following short- and long-term exposure to intraocular silicone oil: an in vivo study. Ophthalmology 1998, 105:1227-1233.
312. Rice TA, Michels RG, Maguire MG, et al. The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol 1983, 95:1.
313. Aaberg TM, Van Horn DL Late complications of pars plana vitreous surgery. Ophthalmology 1978, 85:126.
314. Bopp S, Lucke K, Laqua H Acute onset of rubeosis iridis after diabetic vitrectomy can indicate peripheral traction retinal detachment. Germ J Ophthalmol 1992, 1:375-381.
315. Lee MS, Eliott D, Rastogi S, et al. Incidence of rubeosis after vitrectomy for proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1998, 39:674.
316. Helbig H, Kellner U, Bornfeld N, et al. Rubeosis iridis after vitrectomy for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 1998, 236:730-733.
317. Herschler J, Agness D A modified filtering operation for neovascular glaucoma. Arch Ophthalmol 1979, 97:2339.
318. Parrish R, Herschler J Eyes with end-stage neovascular glaucoma: natural history following successful modified filtering operation. Arch Ophthalmol 1983, 101:745.
319. Rockwood EJ, Parrish RK, Heuer DK, et al. Glaucoma filtering surgery with 5-fluorouracil. Ophthalmology 1987, 94:1071.
320. Ruderman JM, Welch DB, Smith MF, et al. A randomized study of 5-fluorouracil and filtration surgery. Am J Ophthalmol 1987, 104:218.
321. Johnson RN, Flynn HW, Parel JM, et al. Transient hypopyon with marked anterior chamber fibrin following pars plana vitrectomy and silicone oil injection. Arch Ophthalmol 1989, 107:683.
322. Lewis H, Han D, Williams GA Management of fibrin pupillary-block glaucoma after pars plana vitrectomy with intravitreal gas injection. Am J Ophthalmol 1987, 103:180.
323. Sebestyn JG Fibrinoid syndrome: a severe complication of vitrectomy surgery in diabetics. Ann Ophthalmol 1982, 14:853-856.
324. Williams DF, Bennett SR, Abrams GW, et al. Low-dose intraocular tissue plasminogen activator for treatment of postvitrectomy fibrin formation. Am J Ophthalmol 1990, 109:606.
325. Williams GA, Lambrou FH, Jaffe GA, et al. Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator. Arch Ophthalmol 1988, 106:1055-1058.
326. Dabbs CK, Aaberg TM, Aguilar HE, et al. Complications of tissue plasminogen activator therapy after vitrectomy for diabetes. Am J Ophthalmol 1990, 110:354.
327. Iverson DA, Katsura H, Hartzer MK, et al. Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy. Arch Ophthalmol 1991, 109:405.
328. Neely KA, Scroggs MW, McCuen BW Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes. Am J Ophthalmol 1998, 126:82-90.
329. Cherfan GM, El Maghraby AE, Tabbara KF, et al. Dissolution of intraocular fibrinous exudate by streptokinase. Ophthalmology 1991, 98:870.
330. Johnson RN, Olsen K, Hernandez E Tissue plasminogen activator treatment of postoperative intraocular fibrin. Ophthalmology 1988, 95:592.
331. Johnson RN, Olsen KR, Hernandez E Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage. Arch Ophthalmol 1989, 107:891.
332. Steinberg P, Aguilar HE, Drews C, et al. The effect of tissue plasminogen activator on retinal bleeding. Arch Ophthalmol 1990, 108:720.
333. Lewis H, Aaberg TM, Abrams GW, et al. Current causes of failure following diabetic vitrectomy. Invest Ophthalmol Vis Sci 1988, 29:220.
334. Lewis H, Abrams GW, Williams GA Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol 1987, 104:607.
335. Ulbig MR, Hykin PG, Foss AJE, et al. Anterior hyaloidal fibrovascular proliferation after extracapsular cataract extraction in diabetic eyes. Am J Ophthalmol 1993, 115:321-326.
336. Koch FH, Kreiger AE, Spitznas M, et al. Pars plana incisions of four patients: histopathology and electron microscopy. Br J Ophthalmol 1995, 79:486-493.
337. Tardif YM, Schepens CL Closed vitreous surgery. XV. Fibrovascular ingrowth from the pars plana sclerotomy. Arch Ophthalmol 1977, 95:235-239.
338. Charles S IOL as a barrier in vitreoretinal disease: remove it or leave it?. Int J Cataract Surg 1985, 2:24.
339. Lewis H, Abrams GW, Foos RY Clinicopathologic findings in anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol 1987, 104:614.
340. Han DP, Lewandowski MF, Mieler WF Echographic diagnosis of anterior hyaloidal fibrovascular proliferation. Arch Ophthalmol 1991, 109:842.
341. Campo RV, Sipperley JO Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol 1988, 105:432.
342. Blankenship GW Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy. Ophthalmology 1986, 93:39.
343. Joondeph BC, Blankenship GW Hemostatic effects of air versus fluid in diabetic vitrectomy. Ophthalmology 1989, 96:1701.
344. Kerman BM, Kreiger AE, Straatsma BR Resorption of intravitreal blood following vitrectomy. Am J Ophthalmol 1976, 82:915.
345. Novak MA, Rice TA, Michels RG, et al. Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology 1984, 91:1485.
346. Tolentino FL, Cajita VN, Gancayco T, et al. Vitreous hemorrhage after closed vitrectomy for diabetic retinopathy. Ophthalmology 1989, 96:1495.
347. Mieler WF, Wolf MD Management of postvitrectomy diabetic vitreous hemorrhage. Medical and surgical retina: advances, controversies, and management 1994, 330-340. Mosby, St. Louis. H. Lewis, S.J. Ryan (Eds.).
348. Sawa H, Ikeda T, Matsumoto Y, et al. Neovascularization from scleral wound as cause of vitreous rebleeding after vitrectomy for proliferative diabetic retinopathy. Jpn J Ophthalmol 2000, 44:154-160.
349. Hotta K, Hirakata A, Oi Y, et al. Ultrasound biomicroscopy for examination of the sclerotomy sites in eyes with proliferative diabetic retinopathy after vitrectomy. Retina 2000, 20:52-58.
350. Bhende M, Agraharam SG, Gopal L, et al. Ultrasound biomicroscopy of sclerotomy sites after pars plana vitrectomy for diabetic vitreous hemorrhage. Ophthalmology 2000, 107:1729-1736.
351. West JF, Gregor ZJ Fibrovascular ingrowth and recurrent hemorrhage following diabetic vitrectomy. Br J Ophthalmol 2000, 84:822-825. 2000.
352. McLeod D Entry site neovascularization after diabetic vitrectomy. Br J Ophthalmol 2000, 84:810-811.
353. Vote BJ, Gamble GD, Polkinghorne PJ Auckland proliferative diabetic vitrectomy fellow eye study. Clin Exp Ophthalmol 2004, 32:397-403.
354. Liggett PE, Lean JS, Barlow WE, et al. Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhages after vitrectomy for diabetic retinopathy. Am J Ophthalmol 1987, 103:146.
355. de Bustros S, Glaser BM, Michels RG, et al. Effect of e-aminocaproic acid on postvitrectomy hemorrhage. Arch Ophthalmol 1985, 103:219.
356. Blankenship GW Management of postvitrectomy diabetic vitreous hemorrhage. Basic and advanced vitreous surgery 1986, 295-300. Liviana Press, Padova. G.W. Blankenship, S. Binder, M. Stripe (Eds.).
357. Blumenkranz MS, Gardner T, Blankenship G Fluid-gas exchange and photocoagulation after vitrectomy: indications, technique, and results. Arch Ophthalmol 1986, 104:291.
358. Han DP, Murphy ML, Mieler WF, et al. Outpatient fluid-air exchange for severe postvitrectomy diabetic vitreous hemorrhage: long-term results and complications. Retina 1991, 11:309.
359. Landers MB, Robinson D, Olsen KR, et al. Slit-lamp fluid-gas exchange and other office procedures following vitreoretinal surgery. Arch Ophthalmol 1985, 103:967.
360. Martin DF, McCuen BW Efficacy of fluid-air exchange for postvitrectomy diabetic vitreous hemorrhage. Am J Ophthalmol 1992, 114:457-463.
361. Lambrou FH, Devenyi RG, Han DP Fluid-gas exchange after vitrectomy using long-acting gases in an outpatient setting. Arch Ophthalmol 1988, 106:1344.
362. Miller JA, Chandra SR, Stevens TS A modified technique for performing outpatient fluid-air exchange following vitrectomy surgery. Am J Ophthalmol 1986, 101:116.
363. Stern WH, Blumenkranz MS Fluid-gas exchange after vitrectomy. Am J Ophthalmol 1983, 96:400.
364. Williams DF, Peters MA, Abrams GW, et al. A two-stage technique for intraoperative fluid-gas exchange following pars plana vitrectomy. Arch Ophthalmol 1990, 108:1484.
365. Brown GC, Tasman WS, Benson WE, et al. Reoperation following diabetic vitrectomy. Arch Ophthalmol 1992, 110:506-510.
366. Cooper B, Shah GK, Grand MG, et al. Visual outcomes and complications after multiple vitrectomies for diabetic vitreous hemorrhage. Retina 2004, 24:19-22.
367. Cekic O, Batman C Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic patients. Am J Ophthalmol 1999, 127:740. (letter).
368. Neely KA, Scroggs M, McCuen BW Author response. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic patients. Am J Ophthalmol 1999, 127:740-741.
369. Gollamudi SR, Smiddy WE, Schachat AP, et al. Long-term survival rate after vitreous surgery for complications of diabetic retinopathy. Ophthalmology 1991, 98:18.